Especialidades y enfermedades  

Adiciones. 02 de agosto de 2019

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.  
Adiciones. 30 de julio de 2019

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

"It's a point of great pride that our quality systems allow us to be inspected at short notice by any applicable regulatory agency in the world. In this case, we received two separate inspection notices from FDA only seven days and five days in advance of the inspections, respectively. It's an endorsement of the real time monitoring and quality culture we run across all parts of the company," commented Ms. Mei Hao, Vice President of Quality at WuXi STA. "It's another key example of the rigorous nature of our global standard quality systems. It is also another milestone for our platform, and in our efforts to have geographically integrated capabilities for both drug product and drug substance."  
Adiciones. 16 de abril de 2019

‘Japan second fastest pharma growth in 2019’ CPhI Japan report

The trade exhibition (18-20 March, 2019) will open its doors to 20,000 pharma professionals, as industry executives predict Japan to be the second fastest growing mature market for solid dose drugs in 2019, and even more impressively, the second fastest overall country for biologicals growth – finishing only narrowly behind the United States.
Adiciones. 26 de febrero de 2019

Pharma in South East Asia booming as CPhI opens event for the first time in Thailand

Amsterdam, 26 February 2019: CPhI South East Asia’s (March 12-14, 2019) first visit to the fast-growing pharma economy of Thailand could not come at a better moment. The Country is experiencing a boom amongst pharma manufacturers and rising demand for contract services, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.  
Adiciones. 24 de enero de 2019

Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

Paris, 24th January 2019:  Pharmapack Europe (February 6-7th, Paris Expo Porte de Versailles, Paris) has released a ‘European drug delivery and packaging’ report, ahead of the event’s opening which highlights, major challenges and opportunities for the industry in the year ahead.   
Adiciones. 08 de enero de 2019

‘Enjoyable forms’ to see major contract services growth in 2019

04 January, 2019: Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development, innovation and manufacturing organization (CDiMO) – forecasts considerable worldwide growth in outsourced manufacturing and development services for consumer-friendly, ‘enjoyable dosage forms’ in 2019.


Subir notas de prensa y convocatorias

Próximas convocatorias   

No hay próximas convocatorias
Ver todas


Busca notas de prensa por especialidad médica o enfermedad.

Ver todas


Busca notas de prensa por su fecha de edición.

  Selecciona el año

Copyright © 2019, Farmavet, S.L. Todos los derechos reservados.